Molecular mechanisms of carcinogenesis

Carcinogenic and Anticarcinogenic Food Components

Volumn , Issue , 2005, Pages 13-36

  Malejka Giganti, Danuta ^a   Tretyakova, Natalia ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BIOLOGICAL ORGANS; PATHOLOGY; RUBBER INDUSTRY; TEXTILE INDUSTRY;

CANCER DEVELOPMENT; CIGARETTE SMOKING; CLINICAL MANIFESTATION; COMPLEX PROCESSES; MOLECULAR CHANGES; MOLECULAR MECHANISM; OCCUPATIONAL EXPOSURE; URINARY BLADDER CANCER;

DISEASES;

EID: 35848933910     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (109)

1. Abate, C., Patel, L., Rauscher, F.J. III, and Curran, T., Redox regulation of fos and jun DNAbinding activity in vitro, Science, 249, 1157, 1990.
2. Balmain, A. and Harris, C.C., Carcinogenesis in mouse and human cells: parallels and paradoxes, Carcinogenesis, 21, 371, 2000.
3. Barbacid, M., Ras genes, Annu. Rev. Biochem., 56, 779, 1987.
4. Bartsch, H. and Spiegelhalder, B., Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview, Eur. J. Cancer Prev., 5 suppl 1, 11, 1996.
5. Bartsch, H., Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research, Mutat. Res., 462, 255, 2000.
6. Bertram, J.S., The molecular biology of cancer, Mol. Aspects Med., 21, 167, 2001.
7. Besaratinia, A. and Pfeifer, G.P., Weak yet distinct mutagenicity of acrylamide in mammalian cells, J. Natl. Cancer Inst., 95, 889, 2003.
8. Bignold, L.P., Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumors, Carcinogenesis, 25, 299, 2004.
9. Bos, J.L., Ras oncogenes in human cancer: a review, Cancer Res., 49, 4682, 1989.
10. Brennan, P., Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it?, Carcinogenesis, 23, 381, 2002.
11. Christmann, M., Tomicic, M.T., Roos, W.P., and Kaina, B., Mechanisms of human DNA repair: an update, Toxicology, 193, 3, 2003.
12. Chung, F.L., Pan, J., Choudhury, S., Roy, R., Hu, W., and Tang, M.S., Formation of trans-4-hydroxy-2-nonenal-and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation, Mutat. Res., 531, 25, 2003.
13. Cunningham, M.L., Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens, Mutat. Res., 365, 59, 1996.
14. Curran, T. and Franza, R., Fos and jun: the AP-1 connection, Cell, 55, 395, 1988.
15. De Haan, L.H., Simons, J.W., Bos, A.T., Aarts, J.M., Denison, M.S., and Brouwer, A., Inhibition of intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like PCBs in mouse hepatoma cells (Hepa1c1c7): involvement of the Ah receptor, Toxicol. Appl. Pharmacol., 129, 283, 1994.
16. Essigmann, J.M., Croy, R.G., Nadzan, A.M., Busby, W.F. Jr., Reinhold, V.N., Buchi, G., and Wogan, G.N., Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro, Proc. Natl. Acad. Sci. USA, 74, 1870, 1977.
17. 2-(2'-deoxyguanosin-8-yl)PhIP as a biomarker for PhIP exposure, Carcinogenesis, 25, 1053, 2004.
18. Fearon, E.R. and Vogelstein, B., A genetic model for colorectal tumourigenesis, Cell, 61, 758, 1990.
19. Felton, J.S., Knize, M.G., Shen, N.H., Lewis, P.R., Andresen, B.D., Happe, J., and Hatch, F.T., The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Carcinogenesis, 7, 1081, 1986.
20. Field, J.K. and Spandidos, D.A., Oncogenes and tumour-suppressor genes as prognostic indicators in the development of human tumours, in Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth, Pusztai, L., Lewis, C.E., and Yap, E., Eds., Oxford University Press, New York, 1996, chap. 4.
21. Friedberg, E.C., Fischhaber, P.L., and Kisker, C., Error-prone DNA polymerases: novel structures and the benefits of infidelity, Cell, 107, 9, 2001.
22. Fritsche, M., Haessler, C., and Brandner, G., Induction of nuclear accumulation of the tumour suppressor protein p53 by DNA-damaging agents, Oncogene, 8, 307, 1993.
23. Gamboa da Costa, G., Churchwell, M.I., Hamilton L.P., Von Tungeln, L.S., Beland, F.A., Marques, M.M., and Doerge, D.R., DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice, Chem. Res. Toxicol., 16, 1328, 2003.
24. Goodman, M.F., Error-prone repair DNA polymerases in prokaryotes and eukaryotes, Annu. Rev. Biochem., 71, 17, 2002.
25. Gorrod, J.W. and Manson, D., The metabolism of aromatic amines, Xenobiotica, 16, 933, 1986.
26. Graham, M.A., Riley, R.J., and Kerr, D.J., Drug metabolism in carcinogenesis and cancer chemotherapy, Pharmacol. Ther., 51, 275, 1991.
27. Greenblatt, M.S., Bennett, W.P., Hollstein, M., and Harris, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855, 1994.
28. Gregory, C.D., Apoptosis: a role in neoplasia? in Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth, Pusztai, L., Lewis, C.E., and Yap, E., Eds., Oxford University Press, New York, 1996, chap. 13.
29. Hahn, W.C. and Weinberg, R.A., Modelling the molecular circuitry of cancer, Nat. Rev. Cancer, 2, 331, 2002a.
30. Hahn, W.C. and Weinberg, R.A., Rules for making human tumor cells, N. Engl. J. Med., 647, 1593, 2002b.
31. Hall, P.A., McKee, P.H., Menage, H.D., Dover, R., and Lane, D.P., High levels of p53 protein in UV-irradiated normal human skin, Oncogene, 8, 203, 1993.
32. Halliwell, B., Gutteridge, J.M., and Cross, C.E., Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med., 119, 598, 1992.
33. Hamilton, M.L., Van Remmen, H., Drake, J.A., Yang, H., Guo, Z.M., Kewitt, K., Walter, C.A., Richardson, A., and Burcham, P.C., Does oxidative damage to DNA increase with age?, Proc. Natl. Acad. Sci. USA, 98, 10,469, 2001.
34. Hanahan, D. and Weinberg, R.A., The hallmarks of cancer, Cell, 100, 57, 2000.
35. Harris, C.C., p53 tumor suppressor gene: from the basic research laboratory to the clinic-an abridged historical perspective, Carcinogenesis, 17, 1187, 1996a.
36. Harris, C.C., Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies, J. Natl. Cancer Inst., 88, 1442, 1996b.
37. Hecht, S.S., Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis, Proc. Soc. Exp. Biol. Med., 216, 181, 1997.
38. Hemminki, K., DNA adducts, mutations, and cancer, Carcinogenesis, 14, 2007, 1993.
39. Henry, S.H., Bosch, F.X., Troxell, T.C., and Bolger, P.M., Reducing liver cancer: global control of aflatoxin, Science, 286, 2453, 1999.
40. Hites, R.A., Foran, J.A., Carpenter, D.O., Hamilton, M.C., Knuth, B.A., and Schwager, S.J., Global assessment of organic contaminants in farmed salmon, Science, 303, 226, 2004.
41. Hoffmann, D. and Hecht, S.S., Advances in tobacco carcinogenesis, in Handbook of Experimental Pharmacology, vol. 94, Cooper, C.S. and Grover, P.L., Eds., Springer-Verlag, Berlin, 1990, chap. 3.
42. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C., P53 mutations in human cancers, Science, 253, 49, 1991.
43. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., and Harris, C.C., Mutational hot spot in the p53 gene in human hepatocellular carcinomas, Nature, 350, 427, 1991.
44. Hussain, S.P. and Harris, C.C., p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer, Mutat. Res., 428, 23, 1999.
45. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Polynuclear Aromatic Compounds, Part I, Chemical, Environmental, and Experimental Data, vol. 32, IARC, Lyon, 1983.
46. International Agency for Research on Cancer, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Chemicals Used in Plastics and Elastomers, vol. 39, IARC, Lyon, 1986, 41.
47. International Agency for Research on Cancer, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Polychlorinated Dibenzo-para-Dioxins and Polychlorinated Dibenzofurans, vol. 69, IARC, Lyon, 1997.
48. Johnson, K.A., Conformational coupling in DNA polymerase fidelity, Annu. Rev. Biochem., 62, 685, 1993.
49. Johnson, R.E., Washington, M.T., Haracska, L., Prakash, S., and Prakash, L., Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions, Nature, 406, 1015, 2000.
50. Johnson, R.E., Washington, M.T., Prakash, S., and Prakash, L., Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA, Proc. Natl. Acad. Sci. USA, 96, 12,224, 1999.
51. Kakiuchi, H., Watanabe, M., Ushijima, T., Toyota, M., Imai, K., Weisburger, J.H., Sugimura, T., and Nagao, M., Specific 5'-GGGA-3'→5'-GGA-3' mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Proc. Natl. Acad. Sci. USA, 92, 910, 1995.
52. Kriek, E., Rojas, M., Alexandrov, K., and Bartsch, H., Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk, Mutat. Res., 400, 215, 1998.
53. Kumar, V., Cotran, R.S., and Robbins, S.L., Neoplasia, in Robbins Basic Pathology, 7th ed., Kumar, V., Cotran, R.S., and Robbins, S.L., Eds., Saunders, Philadelphia, 2003, chap. 6.
54. Loeb, K.R. and Loeb, L.A., Significance of multiple mutations in cancer, Carcinogenesis, 21, 379, 2000.
55. Loechler, E.L., Green, C.L., and Essigmann, J.M., In vivo mutagenesis by O6-methylguanine built into a unique site in a viral genome, Proc. Natl. Acad. Sci. USA, 81, 6271, 1984.
56. Marcu, B.A., Bossone, S.A., and Patel, A.J., myc function and regulation, Annu. Rev. Biochem., 61, 809, 1992.
57. Marnett, L.J. and Burcham, P.C., Endogenous DNA adducts: potential and paradox, Chem. Res. Toxicol., 6, 771, 1993.
58. Marnett, L.J., Oxyradicals and DNA damage, Carcinogenesis, 21, 361, 2000.
59. Miller, E.C. and Miller, J.A., Mechanisms of chemical carcinogenesis, Cancer, 47, 1055, 1981.
60. Minamoto, T., Mai, M., and Ronai, Z., Environmental factors as regulators and effectors of multistep carcinogenesis, Carcinogenesis, 20, 519, 1999.
61. Mirvish, S.S., Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal, and bladder cancer and contribution to cancer of known exposures to NOC, Cancer Lett., 93, 17, 1995.
62. Mossman, B.T. and Gee, J.B., Asbestos-related diseases, N. Engl. J. Med., 320, 1721, 1989.
63. Mottram, D.S., Wedzicha, B.L., and Dodson, A.T., Food chemistry: acrylamide is formed in the Maillard reaction, Nature, 419, 448, 2002.
64. Nagao, M., A new approach to risk estimation of food-borne carcinogens-heterocyclic amines-based on molecular information, Mutat. Res., 431, 3, 1999.
65. Nagao, M., Ushijima, T., Toyota, M., Inoue, R., and Sugimura, T., Genetic changes induced by heterocyclic amines, Mutat. Res., 376, 161, 1997.
66. Nair, J., Barbin, A., Velic, I., and Bartsch, H., Etheno DNA-base adducts from endogenous reactive species, Mutat. Res., 424, 59, 1999.
67. Nakamura, J. and Swenberg, J.A., Endogenous apurinic/apyrimidinic sites in genomic DNA of mammalian tissues, Cancer Res., 59, 2522, 1999.
68. Naylor, M.S. and Balkwill, F.R., The role of cytokines in tumour progression, in Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth, Pusztai, L., Lewis, C.E., and Yap, E., Eds., Oxford University Press, New York, 1996, chap. 5.
69. Nebert, D.W., Transcription factors and cancer: an overview, Toxicology, 181-182, 131, 2002.
70. Nguyen, T., Brunson, D., Crespi, C.L., Penman, B.W., Wishnok, J.S., and Tannenbaum, S.R., DNA damage and mutation in human cells exposed to nitric oxide in vitro, Proc. Natl. Acad. Sci. USA, 89, 3030, 1992.
71. Norat, T., Lukanova, A., Ferrari, P., and Riboli, E., Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies, Int. J. Cancer, 98, 241, 2002.
72. Osborne, M.R., Beland, F.A., Harvey, R.G., and Brookes, P., The reaction of (+/-)-7alpha, 8beta-dihydroxy-9beta, 10beta-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene with DNA, Int. J. Cancer, 18, 362, 1976.
73. Parodi, S. and Mancuso, T., A general overview of the process of carcinogenesis, Tumori, 82, 291, 1996.
74. Pfau, W., Martin, F.L., Cole, K.J., Venitt, S., Phillips, D.H., Grover, P.L., and Marquardt, H., Heterocyclic amines induce DNA strand breaks and cell transformation, Carcinogenesis, 20, 545, 1999.
75. Phillips, D.H., DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke, Environ. Health Perspect., 104 Suppl 3, 453, 1996.
76. Phillips, D.H., Polycyclic aromatic hydrocarbons in the diet, Mutat. Res., 443, 139, 1999.
77. Pierre, F., Tache, S., Petit, C.R., Van der Meer, R., and Corpet, D.E., Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats, Carcinogenesis, 24, 1683, 2003.
78. Piris, M.A., Sanchez-Beato, M., Villuendas, R., and Martinez, J.C., Oncogenes and tumoursuppressor genes, in Cell Proliferation in Cancer: Regulatory Mechanisms of Neoplastic Cell Growth, Pusztai, L., Lewis, C.E., and Yap, E., Eds., Oxford University Press, New York, 1996, chap. 3.
79. Pitot, H.C. and Sirica, A.E., The stages of initiation and promotion in hepatocarcinogenesis, Biochim. Biophys. Acta, 605, 191, 1980.
80. Poirier, M.C., Santella, R.M., and Weston, A., Carcinogen macromolecular adducts and their measurement, Carcinogenesis, 21, 353, 2000.
81. Poland, A. and Knutson, J.C., 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity, Annu. Rev. Pharmacol. Toxicol., 22, 517, 1982.
82. Qian, G.S., Ross, R.K., Yu, M.C., Yuan, J.M., Gao, Y.T., Henderson, B.E., Wogan, G.N., and Groopman, J.D., A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China, Cancer Epidemiol. Biomarkers Prev., 3, 3, 1994.
83. Randerath, E., Miller, R.H., Mittal, D., Avitts, T.A., Dunsford, H.A., and Randerath, K., Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay, J. Natl. Cancer Inst., 81, 341, 1989.
84. Rideout, W.M. III, Coetzee, G.A., Olumi, A.F., and Jones, P.A., 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes, Science, 249, 1288, 1990.
85. Rojas, M., Cascorbi, I., Alexandrov, K., Kriek, E., Auburtin, G., Mayer, L., Kopp-Schneider, A., Roots, I., and Bartsch, H., Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1, and GSTT1 polymorphism, Carcinogenesis, 21, 35, 2000.
86. Ross, R.K., Yuan, J.M., Yu, M.C., Wogan, G.N., Qian, G.S., Tu, J.T., Groopman, J.D., Gao, Y.T., and Henderson, B.E., Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma, Lancet, 339, 943, 1992.
87. Safe, S.H., Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds, Pharmacol. Ther., 67, 247, 1995.
88. Sawa, T., Akaike, T., Kida, K., Fukushima, Y., Takagi, K., and Maeda, H., Lipid peroxyl radicals from oxidized oils and heme-iron: implication of a high-fat diet in colon carcinogenesis, Cancer Epidemiol. Biomarkers Prev., 7, 1007, 1998.
89. Scherer, G., Frank, S., Riedel, K., Meger-Kossien, I., and Renner, T., Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons, Cancer Epidemiol. Biomarkers Prev., 9, 373, 2000.
90. Schut, H.A.J. and Snyderwine, E.G., DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis, Carcinogenesis, 20, 353, 1999.
91. Schwarz, M., Buchmann, A., Stinchcombe, S., Kalkuhl, A., and Bock, K.-W., Ah receptor ligands and tumor promotion: survival of neoplastic cells, Toxicol. Lett., 112-113, 69, 2000.
92. Segerbäck, D., Calleman, C.J., Schroeder, J.L., Costa, L.G., and Faustman, E.M., Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide, Carcinogenesis, 16, 1161, 1995.
93. Sesink, A.L., Termont, D.S., Kleibeuker, J.H., and Van der Meer, R., Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme, Cancer Res., 59, 5704, 1999.
94. Simic, M.G. and Bergtold, D.S., Dietary modulation of DNA damage in human, Mutat. Res., 250, 17, 1991.
95. Singer, B. and Grunberger, D., Molecular Biology of Mutagens and Carcinogens, Plenum Press, New York, 1983.
96. Slaga, T.J., Mechanisms involved in two-stage carcinogenesis in mouse skin, in Mechanisms of Tumor Promotion: Tumor Promotion and Skin Carcinogenesis, vol. 2., Slaga, T.J., Ed., CRC Press, Boca Raton, FL, 1984, 1.
97. Smela, M.E., Currier, S.S., Bailey, E.A., and Essigmann, J.M., The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis, Carcinogenesis, 22, 535, 2001.
98. Stadler, R.H., Blank, I., Varga, N., Robert, F., Hau, J., Guy, P.A., Robert, M.C., and Riediker, S., Food chemistry: acrylamide from Maillard reaction products, Nature, 419, 449, 2002.
99. Sugimura, T., Nutrition and dietary carcinogens, Carcinogenesis, 21, 387, 2000.
100. Swenberg, J.A., Hoel, D.G., and Magee, P.N., Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine, Cancer Res., 51, 6409, 1991.
101. Talaska, G., Jaeger, M., Reilman, R., Collins, T., and Warshawsky, D., Chronic, topical exposure to benzo[a]pyrene induces relatively high steady-state levels of DNA adducts in target tissues and alters kinetics of adduct loss, Proc. Natl. Acad. Sci. USA, 93, 7789, 1996.
102. Tareke, E., Rydberg, P., Karlsson, P., Eriksson, S., and Törnqvist, M., Analysis of acrylamide, a carcinogen formed in heated foodstuffs, J. Agric. Food Chem., 50, 4998, 2002.
103. Trichopoulos, D., Li, F.P., and Hunter, D.J., What causes cancer?, Sci. Am., 275, 80, 1996.
104. Walker, D.R., Bond, J.P., Tarone, R.E., Harris, C.C., Makalowski, W., Boguski, M.S., and Greenblatt, M.S., Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features, Oncogene, 18, 211, 1999.
105. Weinberg, R.A., Tumor suppressor genes, Science, 254, 1138, 1991.
106. Williams, G.M., Mechanisms of chemical carcinogenesis and application to human cancer risk assessment, Toxicology, 166, 3, 2001.
107. Wogan, G.N., Aflatoxins as risk factors for hepatocellular carcinoma in humans, Cancer Res., 52, 2114s, 1992.
108. Yokota, J., Tumor progression and metastasis, Carcinogenesis, 21, 497, 2000.
109. Zhang, Y., Yuan, F., Wu, X., Wang, M., Rechkoblit, O., Taylor, J.S., Geacintov, N.E., and Wang, Z., Error-free and error-prone lesion bypass by human DNA polymerase kappa in vitro, Nucleic Acids Res., 28, 4138, 2000.